39 research outputs found

    Randomised sham-controlled trial of transcutaneous electrical stimulation in obstructive sleep apnoea

    Get PDF
    Introduction Obstructive sleep apnoea (OSA) is characterised by a loss of neuromuscular tone of the upper airway dilator muscles while asleep. This study investigated the effectiveness of transcutaneous electrical stimulation in patients with OSA. Patients and methods This was a randomised, sham-controlled crossover trial using transcutaneous electrical stimulation of the upper airway dilator muscles in patients with confirmed OSA. Patients were randomly assigned to one night of sham stimulation and one night of active treatment. The primary outcome was the 4% oxygen desaturation index, responders were defined as patients with a reduction >25% in the oxygen desaturation index when compared with sham stimulation and/or with an index <5/hour in the active treatment night. Results In 36 patients (age mean 50.8 (SD 11.2) years, male/female 30/6, body mass index median 29.6 (IQR 26.9–34.9) kg/m2, Epworth Sleepiness Scale 10.5 (4.6) points, oxygen desaturation index median 25.7 (16.0–49.1)/hour, apnoea-hypopnoea index median 28.1 (19.0–57.0)/hour) the primary outcome measure improved when comparing sham stimulation (median 26.9 (17.5–39.5)/hour) with active treatment (median 19.5 (11.6–40.0)/hour; p=0.026), a modest reduction of the mean by 4.1 (95% CI −0.6 to 8.9)/hour. Secondary outcome parameters of patients' perception indicated that stimulation was well tolerated. Responders (47.2%) were predominantly from the mild-to-moderate OSA category. In this subgroup, the oxygen desaturation index was reduced by 10.0 (95% CI 3.9 to 16.0)/hour (p<0.001) and the apnoea-hypopnoea index was reduced by 9.1 (95% CI 2.0 to 16.2)/hour (p=0.004). Conclusion Transcutaneous electrical stimulation of the pharyngeal dilators during a single night in patients with OSA improves upper airway obstruction and is well tolerated

    Parasternal intercostal electromyography: A novel tool to assess respiratory load in children

    Get PDF
    Background: Parasternal intercostal muscle electromyography (EMGpara) represents a novel tool to assess respiratory load when volitional techniques are not possible. This study examined the application of EMGpara in healthy, wheezy, and critically ill children. Methods: Surface EMGpara was measured during tidal breathing in 92 healthy children, 20 wheezy preschool children (with measurements repeated following bronchodilator), and 25 mechanically ventilated children during supported ventilation and on continuous positive airways pressure.Results: EMGpara was related to age, height, and weight in the healthy group (r = -0.623, -0.625, -0.641 respectively, all P < 0.0001). An age-based equation for predicted EMGpara was developed and patient data expressed as z-scores. EMGpara was higher in wheezy children prebronchodilator than healthy controls (median interquartile range (IQR) z-score 0.53 (0.07-1.94), P = 0.0073), falling to levels not different to healthy children postbronchodilator (-0.08 (-0.50-1.00)). In the critically ill children, EMGpara was higher (P < 0.0001) than in healthy subjects during both mechanical ventilation (median (IQR) z-score 1.14 (0.33-1.93)) and continuous positive airways pressure (1.88 (0.91-3.03)).Conclusion: EMGpara is feasible in children and infants both healthy and diseased, is raised in those with elevated respiratory load, and is responsive to clinical interventions. EMGpara represents a potential method to assess respiratory status in patients conventionally challenging to assess

    Pulmonary function at follow up of very preterm infants from the United Kingdom Oscillation Study

    No full text
    Prematurely born infants supported by conventional ventilation frequently have abnormal pulmonary function when assessed in childhood. The aim of this study was to test the hypothesis that infants who were randomly assigned to high frequency oscillatory ventilation would have superior pulmonary function at follow-up to those who received conventional ventilation (United Kingdom Oscillation Study). Infants from 12 trial centres were recruited for pulmonary function testing at a single centre. Seventy-six infants, of mean gestational age 26.4 weeks, were studied following sedation with chloral hydrate at between 11 and 14 months of age, corrected for prematurity. Infants assigned to conventional ventilation had similar pulmonary function to those assigned to high frequency oscillatory ventilation, with mean (SD) results as follows: functional residual capacity measured by whole body plethysmography 26.9 (6.3) vs. 26.5 (6.4) ml/kg; functional residual capacity measured by helium dilution 24.1 (5.4) vs. 23.5 (5.7) ml/kg; inspiratory airway resistance 3.3 (1.3) vs. 3.4 (1.6) kPa/(l/s); expiratory airway resistance 4.4 (2.8) vs. 4.1 (2.5) kPa/(l/s); respiratory rate 31.2 (6.0) vs. 33.9 (8.0) breaths/minute. We conclude that early use of high frequency oscillatory ventilation in very preterm infants appears to offer no advantage over conventional ventilation in terms of pulmonary function at follow-u
    corecore